Login / Signup

Combined Erlotinib and PF-03084014 treatment contributes to synthetic lethality in head and neck squamous cell carcinoma.

Yang ZhengZhao WangXu DingYibo DongWei ZhangWei ZhangYi ZhongWenyi GuYunong WuXiaomeng Song
Published in: Cell proliferation (2017)
These results suggested that concomitant inhibition of the Notch1 and EGFR pathways represented a rational strategy for promoting apoptosis in HNSCC and overcoming treatment resistance.
Keyphrases
  • small cell lung cancer
  • epidermal growth factor receptor
  • oxidative stress
  • cell proliferation
  • endoplasmic reticulum stress
  • tyrosine kinase
  • advanced non small cell lung cancer
  • signaling pathway
  • cell cycle arrest